| Application no. and date | 22183523.4 (espacenet) (Federated) (European Patent Register), 20151116 | | Patent/reg. no. and date | DK/EP 4141032, 20240529 | | Publication date | 20230301 | | Priority no. and date | EP 14194136, 20141120, EP 15152141, 20150122, EP 15167173, 20150511 | | EP pub. no. and date |
EP 4141032 20230301 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P84949DK01 | | Inventor | KLEIN, Christian,
8952 Schlieren, CH,
KARANIKAS, Vaios,
8952 Schlieren, CH,
ZIPPELIUS, Alfred,
4031 Basel, CH,
THOMMEN, Daniela,
4031 Basel, CH,
SCHREINER, Jens,
4031 Basel, CH,
UMAÃ`A, Pablo,
8952 Schlieren, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 47/68 (2017.01) , A61P 1/04 (2006.01) , A61P 11/00 (2006.01) , A61P 13/12 (2006.01) , A61P 15/00 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Kombinationsbehandling med T-celleaktiverende bispecifikke antigenbindende molekyler og PD-1-aksebindende antagonister | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
